Title Credit Type Event date Costsort descending
Difficult Conversations and End of Life Care (5-9-2024)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Live 05/09/2024 - 8:55pm PDT $0.00
Current Treatment Paradigms for Head and Neck Cancers
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Best Practices in the Diagnosis and Management of Homozygous Familial Hypercholesterolemia: Towards Individualized Treatment Strategies
    • 1.00 AMA PRA Category 1 Credit™
 Enduring $0.00
Cancer-Associated Venous Thromboembolism: Anticoagulation Considerations and Controversies (On-Demand)
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC
 Enduring $0.00
Take Note! Charting Accuracy Improves Patient Outcomes and Keeps the Lights On – A Guide to Note-Taking For Solid Tumors (On-Demand)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
 Enduring $0.00
Innovative Approaches to Managing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
    • 1.50 AMA PRA Category 1 Credit™
 Enduring $0.00
Oral Oncoloytic Therapy: How to Optimize Your Patients' Care
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Breaking Barriers: Addressing Disparities in COPD Management
    • 0.25 AMA PRA Category 1 Credit™
 Enduring $0.00
Genetic Testing and Counseling in the Community Setting: Germline and Somatic
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Radiation Therapy: Management of Acute and Long-Term Toxicities
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00
Navigating the Terrain: Insights into the Current Landscape, Treatment Strategies, and a Clinical Trial of Triple Negative Breast Cancer
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00
Gynecologic Oncology: Pelvic Mass and Abnormal Bleeding
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Cardiotoxicity in Oncology Patients: Risks, Diagnostics, and Interventions
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Updates in Management of Advanced Renal Cell Carcinoma: Making Sense of the Menu
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Treating Cancer with Bispecific Antibodies: Current Status and Future Directions
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00

Pages